Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eduardo E. Vargas-Pozada
Observed names:
E.E. Vargas-Pozada,
Eduardo E. Vargas Pozada,
Eduardo Enrique Vargas-Pozada
Institution:
Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional
Observed institutions:
Instituto Politécnico Nacional,
Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional
ORCID:
0000-0002-9601-5893
Observed ORCID:
0000-0002-9601-5893
OpenAlex ID:
A5043622706
Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model
2022
·
Eduardo E. Vargas-Pozada
, Erika Ramos-Tovar
, et al.
·
International Journal of Molecular Sciences
·
58
PDF
Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways
2022
·
Eduardo E. Vargas-Pozada
, Erika Ramos-Tovar
, et al.
·
Annals of Hepatology
·
34
PDF
Antioxidant, Antiinflammatory, and Antifibrotic Properties of Quercetin in the Liver
2017
·
L.F. Vázquez-Flores
, S. Casas-Grajales
, et al.
·
Elsevier eBooks
·
29
Serum α-SMA is a potential noninvasive biomarker of liver fibrosis
2023
·
Irina Cardoso-Lezama
, Erika Ramos-Tovar
, et al.
·
Toxicology Mechanisms and Methods
·
28
Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathway
2023
·
Irina Cardoso-Lezama
, Miguel Á. Fuentes-Figueroa
, et al.
·
Biochemical Pharmacology
·
27
The antioxidant and anti-inflammatory activities of caffeine effectively attenuate nonalcoholic steatohepatitis and thioacetamide-induced hepatic injury in male rats
2023
·
Eduardo E. Vargas-Pozada
, Erika Ramos-Tovar
, et al.
·
Canadian Journal of Physiology and Pharmacology
·
19
Herbal medicines for the liver: from bench to bedside
2019
·
Eduardo E. Vargas-Pozada
, Pablo Muriel
·
European Journal of Gastroenterology & Hepatology
·
17
Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH
2022
·
Eduardo E. Vargas-Pozada
, Erika Ramos-Tovar
, et al.
·
Annals of Hepatology
·
15
PDF
Coffee for the liver: a mechanistic approach
2025
·
Eduardo E. Vargas-Pozada
, Erika Ramos-Tovar
, et al.
·
Biochemical Pharmacology
·
10
Potential Therapeutic Strategies for Steatosis, Oxidative Stress, Inflammation, and Fibrosis in Liver Disease
2026
·
Pablo Muriel
, Eduardo E. Vargas-Pozada
, et al.
·
International Journal of Molecular Sciences
·
8
PDF
Naringenin attenuates early hepatocarcinogenesis induced by a MASH model
2025
·
Linda Vanessa Márquez-Quiroga
, Aline Barboza-López
, et al.
·
Annals of Hepatology
·
6
The progression of metabolic dysfunction-associated steatotic liver disease toward hepatocellular carcinoma in an efficient rat model
2025
·
Linda Vanessa Márquez-Quiroga
, Irina Cardoso-Lezama
, et al.
·
Biochemical Pharmacology
·
5
Chronological activation of the NLRP3 inflammasome/pyroptosis pathway in the progression from metabolic dysfunction-associated fatty liver disease to hepatocellular carcinoma
2025
·
Linda Vanessa Márquez-Quiroga
, Eduardo E. Vargas-Pozada
, et al.
·
Toxicology Mechanisms and Methods
·
5
Mechanisms of non-alcoholic fatty liver disease development in normal-weight individuals
2023
·
Pablo Muriel
, Irina Cardoso-Lezama
, et al.
·
European Journal of Gastroenterology & Hepatology
·
4
Involvement of the hedgehog signaling pathway in liver diseases
2025
·
Karla Jocelyn Ortega-Carballo
, Eduardo Enrique Vargas-Pozada
, et al.
·
Annals of Hepatology
·
3
Metformin for the treatment of chronic liver disease: Mechanistic rationale, translational evidence, and repurposing opportunities
2026
·
Eduardo E. Vargas-Pozada
, Erika Ramos-Tovar
, et al.
·
Biochemical Pharmacology
PDF
Critical Mediators of Inflammation-driven Hepatocarcinogenesis Induced by Metabolic Dysfunction-associated Steatotic Liver Disease
2025
·
Linda Vanessa Márquez Quiroga
, Eduardo E. Vargas Pozada
, et al.
·
Annals of Hepatology
The importance of fundamental pharmacology in fighting liver diseases
2024
·
Eduardo E. Vargas-Pozada
, Erika Ramos-Tovar
, et al.
·
Annals of Hepatology
List of Contributors
2017
·
L. Abenavoli
, J.G. Abraldes
, et al.
·
Elsevier eBooks
Show more works
View as search
Works count:
19
Citation count:
268
H-index:
9
I10-index:
9
Year
Topic
Type